Modulation of Thiopurine Metabolism by Anti-TNF Therapy

被引：0
|
作者：
Yoon, Jessica L.
Huang, Brian L.
Melmed, Gil Y.
Amin, Jaimin
Ippoliti, Andrew
Dubinsky, Marla
Khanna, Puja
Fleshner, Phillip
McGovern, Dermot P.
Targan, Stephan
Vasiliauskas, Eric A.
Shih, David Q.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1239
引用
收藏
页码：S239 / S240
页数：2
相关论文
共 50 条
  • [21] Hypertriglyceridemia during anti-TNF therapy
    Javot, L.
    Scala-Bertola, J.
    Petitpain, N.
    Peyrin-Biroulet, L.
    Got, I.
    Pere, P.
    Gillet, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 38 - 39
  • [22] Anti-TNFα therapy and vaccination of adults
    Duchet-Niedziolka, Paula
    Coutsinos, Zoe
    Hanslik, Thomas
    Launay, Odile
    JOINT BONE SPINE, 2007, 74 (06) : 563 - 565
  • [23] Maintaining and optimising anti-TNF therapy
    Somerville, Margaret
    MUSCULOSKELETAL CARE, 2007, 5 : 1 - 17
  • [24] The role of anti-TNF therapy in practice
    Rahiman, Mumtaz Abdool
    van der Merwe, Elsabe
    SA PHARMACEUTICAL JOURNAL, 2008, 75 (08) : 46 - 53
  • [25] The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
    Chamaida Plasencia
    Dora Pascual-Salcedo
    Sara García-Carazo
    Leticia Lojo
    Laura Nuño
    Alejandro Villalba
    Diana Peiteado
    Florencia Arribas
    Jesus Díez
    Maria Teresa López-Casla
    Emilio Martín-Mola
    Alejandro Balsa
    Arthritis Research & Therapy, 15
  • [26] The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
    Plasencia, Chamaida
    Pascual-Salcedo, Dora
    Garcia-Carazo, Sara
    Lojo, Leticia
    Nuno, Laura
    Villalba, Alejandro
    Peiteado, Diana
    Arribas, Florencia
    Diez, Jesus
    Teresa Lopez-Casla, Maria
    Martin-Mola, Emilio
    Balsa, Alejandro
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (04)
  • [27] EVALUATION OF BONE METABOLISM DURING ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASES
    Petruzzellis, C.
    Sparano, L.
    Cesari, P.
    Boselli, C.
    Pagani, F.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E194 - E194
  • [28] Influence of anti-TNF therapy on bone metabolism in patients with inflammatory bowel disease
    Castro, Beatriz
    Rivero, Montserrat
    Crespo, Javier
    Antonio Riancho, J.
    Valero, Carmen
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 39 : E33 - E34
  • [29] A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report
    Merhaben, Salma
    Ayadi, Shema
    Tangour, Monia
    Boujelbene, Nadia
    Ghariani, Rayfa
    Mouelhi, Leila
    Merhaben, Fathi
    FUTURE SCIENCE OA, 2023,
  • [30] Lack of response to first anti-TNFα agent should not preclude alternative anti-TNFα therapy
    Pringle, J.
    Stirling, A.
    Gordon, M. M.
    RHEUMATOLOGY, 2007, 46 : I29 - I30
12345